Halcinonide Topical Solution
NDC Package 74157-012-12

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Halcinonide Topical Solution (halcinonide topical) solution is a medication used to treat a variety of skin conditions (e.g., eczema, dermatitis, allergies, rash). This formulation utilizes a solution delivery system. Marketed by Ina Pharmaceutics Inc, this product is identified by NDC 74157-012 and is authorized under FDA application ANDA217671.

Identification & Billing

NDC Package Code
74157-012-12
Package Description
1 BOTTLE, PLASTIC in 1 CARTON / 120 mL in 1 BOTTLE, PLASTIC
Product Code
11-Digit Billing Format
74157001212
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Halcinonide Topical Solution
Non-Proprietary Name
Halcinonide Topical
Substance Name
Halcinonide
Dosage Form
Solution - A clear, homogeneous liquid1 dosage form that contains one or more chemical substances dissolved in a solvent or mixture of mutually miscible solvents.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
Usage Information
This medication is used to treat a variety of skin conditions (e.g., eczema, dermatitis, allergies, rash). Halcinonide reduces the swelling, itching, and redness that can occur in these types of conditions. This medication is a strong corticosteroid.

Regulatory & Marketing

Labeler Name
Ina Pharmaceutics Inc
Product Type
Human Prescription Drug
FDA Application #
ANDA217671
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
01-29-2025
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 74157-012-12 identifies a specific commercial package of 1 bottle, plastic in 1 carton / 120 ml in 1 bottle, plastic of Halcinonide Topical Solution, a human prescription drug labeled by Ina Pharmaceutics Inc. This solution is formulated for topical use and contains halcinonide as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Ina Pharmaceutics Inc on January 29, 2025. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This medication is used to treat a variety of skin conditions (e.g., eczema, dermatitis, allergies, rash). Halcinonide reduces the swelling, itching, and redness that can occur in these types of conditions. This medication is a strong corticosteroid.

How is this Ina Pharmaceutics Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 74157001212. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
74157-012-12
11-Digit CMS (5-4-2)
74157-0012-12

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.